X-linked agammaglobulinemia caused by new mutation in BTK gene: a case report
Jazyk angličtina Země Česko Médium print-electronic
Typ dokumentu kazuistiky, časopisecké články
PubMed
23549506
DOI
10.5507/bp.2013.011
Knihovny.cz E-zdroje
- MeSH
- agamaglobulinemie farmakoterapie genetika MeSH
- dítě MeSH
- genetické nemoci vázané na chromozom X farmakoterapie genetika MeSH
- intravenózní imunoglobuliny terapeutické užití MeSH
- lidé MeSH
- mutace * MeSH
- proteinkinasa BTK MeSH
- tyrosinkinasy genetika MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- Názvy látek
- BTK protein, human MeSH Prohlížeč
- intravenózní imunoglobuliny MeSH
- proteinkinasa BTK MeSH
- tyrosinkinasy MeSH
AIM: Primary immunodeficiencies (PID) are becoming a recognized public health problem worldwide. The most important subgroup of these disorders are the antibody deficiencies. X-linked agammaglobulinaemia was the first described entity of this group and is characterised by early onset of recurrent bacterial infections, profound deficiency of all immunoglobulin isotypes and markedly reduced number of peripheral B-lymphocytes. CASE REPORT: We report the case of a 10-year old boy with X-linked agammaglobulinaemia caused by a previously non-described mutation in BTK gene with typical clinical presentation but delayed diagnosis. Following diagnosis, substitution therapy with intravenous immunoglobulins was started and the clinical status of the patient improved. CONCLUSION: We reported a case of X-linked agammaglobulinaemia with delayed diagnosis despite the typical anamnestic signs for primary humoral immunodeficiency. The disease was caused by a previously non-reported mutation in the BTK gene. Measurement of serum immunoglobulins should be performed in all children with recurrent, complicated respiratory infections as a screening test for humoral immunodeficiencies.
Citace poskytuje Crossref.org